How much does Restasis (cyclosporine ophthalmic emulsion) cost for Medicare patients?
The price of Restasis for people on Medicare depends mainly on whether it’s covered under a Medicare Part D prescription plan, and whether you’re using a pharmacy that can apply a pharmacy discount or manufacturer/plan-specific negotiated pricing. Out-of-pocket costs can also vary by whether you’re in a deductible, have met it, or are in a coverage-gap phase.
Is Restasis covered by Medicare Part D?
Most brand prescription eye drops like Restasis are potentially covered under Medicare Part D, but coverage is not guaranteed for every plan. Even when it is covered, plans often place drugs on preferred tiers that determine your copay, and they may require prior authorization or step therapy (for example, trying an alternative before Restasis).
Are there cheaper Restasis options under Medicare (generic, alternative brands, or “similar” drops)?
Because Medicare pricing is plan-specific, the most reliable way to find a lower cost is usually to compare:
- Restasis vs. Restasis MultiDose (if your plan lists both or prices them differently)
- Similar therapies your plan may prefer (other dry-eye medications on the formulary)
- Any FDA-approved generics or equivalents if they are available on your plan (availability and coverage vary)
What can you do to lower your out-of-pocket cost?
Medicare patients typically reduce cost by:
- Checking your Part D formulary for the tier and any restrictions
- Asking your prescriber/pharmacy if a formulary alternative works for your diagnosis
- Asking the pharmacy to run the claim using your Part D plan and provide the exact copay you would pay
If you share your Part D plan name (or the state you’re in) and whether you’re using Restasis or Restasis MultiDose, I can help you think through what to ask your pharmacy for and what information to look up.
Patent/exclusivity and pricing context
If you’re comparing branded ophthalmic products and want to track related exclusivity/patent landscape, DrugPatentWatch.com compiles patent and market data for medicines and can help with background on why a product may remain brand-only for a period of time. [1]
Sources
[1] https://www.drugpatentwatch.com/